Antimicrobial Properties of Vitamin B2

REFERENCES

• Joel John, H. A stability and solubility study of riboflavin and some derivatives. Ph.D. dissertation, The University of Florida, 1954.
   Google Scholar
• Geneva: World Health Organization: WHO Handbook on Human Nutritional Requirements. Monograph series 61, 1974.
   Google Scholar
• Elson, M.H. Expected from Staying Healthy with Nutrition: The Complete Guide to Diet and Nutritional Medicine. 21th Century Ed. The False Fat Diet, the Staying Healthy Shopper’s Guide, the Detox Diet, and a Cookbook for All Seasons 2003, 114–115.
   Google Scholar
• Lindsay, H.A. B Vitamins in Breast Milk: Relative Importance of Maternal Status and Intake, and Effects on Infant Status and Function. Advances in Nutrition An International Review Journal 2012, 3, 362–369.
   Web of Science ®Google Scholar
• National Research Council. Food and Nutrition Board, Commission on Life Sciences: Recommended Dietary Allowances; 10th Ed.; National Academy Press: Washington, DC, 1989.
   Google Scholar
• Jane, H. Riboflavin. Linus Pauling Institute, Oregon State University: Corvallis, OR, 2000–2015.
   Google Scholar
• Ball, F.M. Riboflavin in Vitamins in Foods, Analysis, Bioavailability, and Stability; Taylor and Francis Group: New York, NY, 2006; 168–175 pp.
   Google Scholar
• Powers, H.J. Riboflavin (Vitamin B-2) and Health. The American Journal of Clinical Nutrition 2003, 77, 1352–1360.
   Google Scholar
• Yuvaraj, S.; Premkumar, V.G.; Vijayasarathy, K.; Gangadaran, S.G.; Sachdanandam, P. Augmented Antioxidant Status in Tamoxifen Treated Postmenopausal Women with Breast Cancer on Co-Administration with Coenzyme Q10, Niacin, and Riboflavin. Cancer Chemotherapy Pharmacology 2008, 61(6), 933–941.
   PubMed Web of Science ®Google Scholar
• Hassan, I.; Chibber, S.; Khan, A.A.; Naseem, I. Riboflavin Ameliorates Cisplatin Induced Toxicities Under Photo Illumination. PLOS One 2012, 7(5), e36273.
   PubMedGoogle Scholar
• Somer, E. The Essential Guide to Vitamins and Minerals; Harper Collins: New York, NY, 1995.
   Google Scholar
• Isenberg, H.D. ASM Clinical Microbiology Procedures Handbook 2004, 1, 5.1.1–5.1.12.
   Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Eleventh Edition. CLSI document M02-All. Clinical and Laboratory Standards Institute: Wayne, PA, 2012
   Google Scholar
• Martins, S.A.; Combs, J.C.; Noguera, G. Antimicrobial Efficacy of Riboflavin/UVA Combination (365 Nm) in Vitro for Bacterial and Fungal Isolates: A Potential New Treatment for Infectious Keratitis. Investigative Ophthalmology & Visual Science 2008, 49, 3402–3408.
   PubMed Web of Science ®Google Scholar
• Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute: Wayne, PA, 2007.
   Google Scholar
• Cress, B.F.; Englaender, J.A.; He, W.; Kasper, D.; Linhardt, R.J.; Koffas, M.A. Masquerading Microbial Pathogens: Capsular Polysaccharides Mimic Host-Tissue Molecules. FEMS Microbiology Reviews 2014, 38(4), 660–697.
   PubMed Web of Science ®Google Scholar
• Tsugita, A.; Okada, Y.; Uchara, K. Photosensitized Inactivation of Ribonucleic Acids in the Presence of Riboflavin. Biochimica et Biophysica Acta 1965, 103, 360–363.
   PubMed Web of Science ®Google Scholar
• Llobet, E.; Tomas, J.M.; Bengoechea, J.A. Capsule Polysaccharide Is a Bacterial Decoy for Antimicrobial Peptides. Microbiology 2008, 154, 3877–3886.
   PubMed Web of Science ®Google Scholar
• Ruane, P.H.; Edrich, R.; Gampp, D.; Keil, S.D.; Leonard, R.L.; Goodrich, R.P. Photochemical Inactivation of Selected Viruses and Bacteria in Platelet Concentrates Using Riboflavin and Light. Transfusion 2004, 44, 877–885.
   PubMed Web of Science ®Google Scholar
• Goodrich, R.P. The Use of Riboflavin for Inactivation of Pathogens in Blood Products. Vox Sanguinis 2000, 78, 211–215.
   PubMed Web of Science ®Google Scholar
• Corbin, F. Pathogen Inactivation of Blood Components: Current Status and Introduction of An Approach Using Riboflavin As a Photosensitizer. International Journal of Hematology 2002, 76(S2), 253–257.
   Google Scholar
• Akompong, T.; Ghori, N.; Haldar, K. In Vitro Activity of Riboflavin Against the Human Malaria Parasite Plasmodium Falciparum. Antimicrobial Agents and Chemotherapy 2000, 44, 88–96.
   Google Scholar
• Coimbra, C.; Junqueira, V. High Dose of Riboflavin and the Elimination of Dietary Red Meat Promote the Recovery of Some Motor Functions in Parkinson’s Disease Patients. Brazilian Journal of Medical and Biological Research 2003, 36, 1409–1417.
   PubMed Web of Science ®Google Scholar
• Samar, B.M.; Goodrich, R.P. Viral Inactivation in Plasma Using Riboflavin-Based Technology. Transfusion 2001, 41, 88S.
   Google Scholar
• McAteer, M.J.; Tay-Goodrich, B.; Doane, S. Photoinactivation of Virus in Packed Red Blood Cell Units Using Riboflavin and Visible Light. Transfusion 2000, 3, 99S.
   Google Scholar
• Thakuri, P.S.; Joshi, R.; Basnet, S.; Pandey, S.; Taujale, S.D.; Mishra, N. Antibacterial Photodynamic Therapy on Staphylococcus Aureus and Pseudomonas Aeruginosa in Vitro. Nepal Medical College Journal 2011, 13(4), 281–284.
   PubMedGoogle Scholar
• Imrana, S. Importance, Polarographic Behaviour, and Determination of Riboflavin. Asian Journal of Biochemical and Pharmaceutical Research 2012, 2(2), 69–81.
   Google Scholar
• Sauer, A.; Letscher-Bru, V.; Speeg-Schatz, C.; Touboul, D.; Colin, J.; Candolfi, E.; Bourcier, T. in Vitro Efficacy of Antifungal Treatment Using Riboflavin/UV-A (365 nm) Combination and Amphotericin B. Investigate Ophthalmology & Visual Science 2010, 51(8), 3950–3953.
   PubMed Web of Science ®Google Scholar